The Lupus Research Institute (LRI) urges the lupus community to back a new bill introduced by Senator Tom Harkin (D-IA) to support biomedical research at the National Institutes of Health. If passed, the ‘‘Accelerating Biomedical Research Act” will raise the cap on potential budget appropriations to the NIH and establish a consistent, reliable source of funding that scientists can count on in as they develop research projects in the future.
Click here to use the LRI’s Legislative Action Center to urge U.S. Senators in your state to co-sponsor this bill.
Attracting and sustaining the finest scientific minds to biomedical research, particularly in lupus and autoimmunity, has been a top priority for the LRI for more than a decade. Having awarded over $42 million in 154 grants to date, the LRI’s investment has afforded scientists throughout the country the opportunity to initiate studies, make breakthroughs and obtain highly competitive NIH funding to continue their research. That funding from the NIH is what allows our scientists to push forward along the continuum from discovery to drug development, from innovation to improved care.
Previous budget cuts have hampered the ability of the NIH to pursue many promising research areas and to maintain U.S. global leadership in biomedical research and development.
Along with more than 100 patient groups and research institutions, the Lupus Research Institute calls on Congress to pass the “Accelerating Biomedical Research Act”. As members of the national lupus community, you can help get this bill passed by voicing your support to your Senators by email or phone. With this legislation, we can ensure that the NIH receives the funding necessary to deliver the much-needed medical advances of tomorrow – for people with lupus and the many other chronic diseases affecting millions of Americans.
Click here to read the Bill proposed by Senator Harkin in its entirety.